Completed
Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients
NCT01420146
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Positive Carcinoma of Breast, +9 more
- Locations
-
- Jules Bordet Institut Brussels, Brussels Capital, Belgium